Jefferies Group’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Jefferies Group’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-20,000	Closed	-$403K	–	2163
2021 Q3	$403K	Buy	+20,000	New	+$552K	﹤0.01%	1295

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Jefferies Group's DRNA Position: Q4 2021 in Review

Jefferies Group sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 20,004 shares — an estimated $403K sold.

Jefferies Group first reported a position in DRNA in Q3 2021 and held it in 1 quarter. The position peaked at $403K in Q3 2021. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Jefferies Group reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Jefferies Group sold 20,004 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $403K.
Jefferies Group first reported a position in Dicerna Pharmaceuticals, Inc. in Q3 2021 and held it in 1 quarter.
Jefferies Group's Dicerna Pharmaceuticals, Inc. position peaked at $403K in Q3 2021.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Jefferies Group's 13F filing for Q4 2021, filed 14 Feb 2022.